InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Pfeil Keith W, 首席财务官. Director active across 1 company, notably Globus Medical INC. Cumulatively, 9 disclosures have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 10 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pfeil Keith W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
5,833 股@ US$49.6510.1% 占其流量Class A Common StockSEC:0000950170-25-005353:0
833 股@ US$49.651.3% 占其流量Class A Common StockSEC:0001209191-23-007310:0
14,167 股@ US$49.6523.0% 占其流量Class A Common StockSEC:0001209191-23-007323:0
833 股@ US$53.272.1% 占其流量Class A Common StockSEC:0001209191-21-052968:0
833 股@ US$53.272.0% 占其流量Class A Common StockSEC:0001209191-21-049452:0
834 股@ US$49.651.9% 占其流量Class A Common StockSEC:0001209191-21-047369:0
833 股@ US$53.272.0% 占其流量Class A Common StockSEC:0001209191-21-045571:0
13,312 股@ US$49.6530.3% 占其流量Class A Common StockSEC:0001209191-21-043495:0
5,021 股@ US$49.6511.1% 占其流量Class A Common StockSEC:0001209191-21-030906:0
9 条申报中的 9 条
About Pfeil Keith W
Pfeil Keith W serves as Chief Financial Officer and Senior Vice President at GLOBUS MEDICAL INC. He is responsible for the company's financial management, including financial planning, risk management, and financial reporting. His expertise in finance and strategy enables him to contribute to the growth and profitability of GLOBUS MEDICAL. Pfeil Keith W plays a crucial role in making informed financial decisions and optimizing the company's resources.
